Dr. Thomas McGinn answers questions on comorbidities that are key factors in the acuity of COVID-19
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
•
Apr 29, 2020, 1:38 PM
•
Updated 1,702 days ago
Share:
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
Dr. McGinn was co-author on a JAMA paper about a study that linked hypertension, obesity and diabetes as comorbidities (the simultaneous presence of two chronic diseases or conditions in a patient) as key factors in the acuity of COVID-19 in some patients.
More from News 12
2:32
About 20,000 affected by Edison water main break
1:41
Dry and sunny Thursday ahead of weekend rain in New Jersey
1:34
Sinkhole in Wharton halts traffic on I-80
0:32
Former NJ lieutenant killed in line of duty in North Carolina
0:17
Late night fire destroys home in Old Bridge
1:13
